SIGY · Sigyn Therapeutics, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“The Company had an accumulated deficit of $17,379,978 at September 30, 2025, had a working capital deficit of $3,903,920 at September 30, 2025, had net losses of $578,503 and $2,698,254, and $1,196,923 and $2,817,394 for the three and nine months ended September 30, 2025 and 2024, respectively, and net cash used in operating activities of $646,208 and $582,218 for the nine months ended September 30, 2025 and 2024, respectively, with no revenue earned since inception, and a lack of operational history. These matters raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Nov 14, 2025
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of SIGY in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns SIGY
13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positions| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 53,000 | 3.30% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 160,537 | 10.00% |
| Remaining | 1,391,840 | 86.70% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 1,605,377, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of SIGY
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
Brio Capital Master Fund Ltd.
13G
CIK 1560894 · Unknown · Dec 31, 2025
Rule 13d-1(c), passive investor
|
160,537 | ||
| 2 |
Howard Capital Management Group, LLC
13F
CIK 1860501 · Registered investment adviser · Sep 30, 2026
|
53,000 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.